Therapeutic Neovascularization – Quo vadis?
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Dordrecht
Springer Netherlands
2007, 2007
|
Edition: | 1st ed. 2007 |
Subjects: | |
Online Access: | |
Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease
- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis
- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction
- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword
- Pampering and Priming the Heart
- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization
- Integrative Pro-angiogenic Activation: HIF-?
- The Maturation of Vessels – A Limitation to Forced Neovascularization?
- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads
- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis
- The Biology of Embryonic and Adult Endothelial Progenitor Cells
- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin
- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth